Comparison of tumor‐informed and tumor‐naïve sequencing assays for ctDNA detection in breast cancer
Ángela Santonja(University of Cambridge), Davina Gale(University of Cambridge), Jean Abraham(Cancer Research UK), Wendy N. Cooper(University of Cambridge), Katrin Heider(University of Cambridge), Paulius Mennea(University of Cambridge), Stephen‐John Sammut(Cambridge University Hospitals NHS Foundation Trust), Raquel Manzano García(University of Cambridge), Hui Zhao(Jiangnan University), Christopher G. Smith(University of Cambridge), Aadhitthya Vijayaraghavan(University of Cambridge), Chris Boursnell(University of Cambridge), Nitzan Rosenfeld(Queen Mary University of London), Paul A. Edwards(University of Cambridge), A. Edwards(University of Cambridge), E. J. Ditter(University of Cambridge), Dominique‐Laurent Couturier(University of Cambridge), Emma Beddowes(University of Cambridge), Carlos Caldas(University of Cambridge), James Morris(University of Cambridge), Heather Biggs(University of Cambridge), Matthew Eldridge(University of Cambridge), Oscar M. Rueda(University of Cambridge)
Cited by 60
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Liquid biopsies come of age: towards implementation of circulating tumour DNA
|Nature reviews. Cancer|2017|2.6k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
Dynamics of the p53-Mdm2 feedback loop in individual cells
|Nature Genetics|2004|1k